Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jean Bourgouin | M | - |
Kaneq Bioscience Ltd.
Kaneq Bioscience Ltd. BiotechnologyHealth Technology Kaneq Bioscience Ltd. operates as a biotechnology company focuses on developing treatments for type 2 diabetes. The firm develops a protein tyrosine phosphatase1B inhibitor for treating type 2 diabetes mellitus. The company was founded by Jean Bourgouin on October 19, 2012 and is headquartered in Montreal, Canada. | 12 years |
Cynthia Lavoie | M | - |
Kaneq Bioscience Ltd.
Kaneq Bioscience Ltd. BiotechnologyHealth Technology Kaneq Bioscience Ltd. operates as a biotechnology company focuses on developing treatments for type 2 diabetes. The firm develops a protein tyrosine phosphatase1B inhibitor for treating type 2 diabetes mellitus. The company was founded by Jean Bourgouin on October 19, 2012 and is headquartered in Montreal, Canada. | 11 years |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 2 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Philippe Tessier
- Personal Network